Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABSW) Interest Coverage Ratio (2021 - 2025)

SAB Biotherapeutics' Interest Coverage Ratio history spans 5 years, with the latest figure at 248.5 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 75.97% year-over-year to 248.5; the TTM value through Dec 2025 reached 203.41, down 50.93%, while the annual FY2025 figure was 203.41, 50.93% down from the prior year.
  • Interest Coverage Ratio reached 248.5 in Q4 2025 per SABSW's latest filing, up from 292.87 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 10.82 in Q1 2021 to a low of 292.87 in Q3 2025.
  • Average Interest Coverage Ratio over 5 years is 122.58, with a median of 110.05 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: crashed 960.35% in 2022, then skyrocketed 41.73% in 2024.
  • A 5-year view of Interest Coverage Ratio shows it stood at 110.81 in 2021, then increased by 19.12% to 89.62 in 2022, then plummeted by 170.4% to 242.35 in 2023, then surged by 41.73% to 141.22 in 2024, then crashed by 75.97% to 248.5 in 2025.
  • Per Business Quant, the three most recent readings for SABSW's Interest Coverage Ratio are 248.5 (Q4 2025), 292.87 (Q3 2025), and 151.25 (Q2 2025).